Sovereign Wealth Capital Invests in Moximed

Hayward, California-based Moximed, Inc., a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA), raised a US$ 50 million Series C round. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]



Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute


 
institutional investor investment mandates